Eyal Rubin's Net Worth
$859 Thousand
Who is Eyal Rubin?
Eyal Rubin does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include BRAINSTORM CELL THERAPEUTICS INC., and Protalix BioTherapeutics, Inc..
SEC CIK
Eyal Rubin's CIK is 0001721411
Past Insider Trading and Trends
2017 was Eyal Rubin's most active year for acquiring shares with 2 total transactions. Eyal Rubin's most active month to acquire stocks was the month of July. 2019 saw Eyal Rubin paying a total of $0.00 for 800,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Snapshot price: $0.3849
CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Nov 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Protalix BioTherapeutics, Inc. (PLX) Snapshot price: $1.49
Sr. VP and CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +54.85% | 201.9K |
—
|
—
| 570K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
| +49.54% | 121.95K |
—
|
—
| 368.1K |
Feb 25
| |||
Form 4/A
|
∞
| 246.15K |
—
|
—
| 246.15K |
Aug 11
| |||
Form 4
|
∞
| 246.15K |
—
|
—
| 246.15K |
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |